Maristela Y Nabong-nillas, MD in Mesa, AZ - Medicare Pediatrics

Maristela Y Nabong-nillas, MD is a medicare enrolled "Pediatrics" physician in Mesa, Arizona. Her current practice location is 1705 W Main St, Mesa, Arizona. You can reach out to her office (for appointments etc.) via phone at (623) 583-3001.

Maristela Y Nabong-nillas is licensed to practice in South Carolina (license number 30745) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1629155338.

Contact Information

	Maristela Y Nabong-nillas, MD
	1705 W Main St, Mesa, AZ 85201-6920
	(623) 583-3001
	Not Available

Physician's Profile

Full Name	Maristela Y Nabong-nillas
Gender	Female
Speciality	Pediatrics
Location	1705 W Main St, Mesa, Arizona
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1629155338
Provider Enumeration Date: 11/01/2006
Last Update Date: 01/11/2021

Medicare PECOS Information:

PECOS PAC ID: 9436214574
Enrollment ID: I20201214002084

Medical Identifiers

Medical identifiers for Maristela Y Nabong-nillas such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1629155338	NPI	-	NPPES
6961002	Medicaid	NJ
082796	Medicaid	AZ
307457	Medicaid	SC

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	30745 (South Carolina)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Maristela Y Nabong-nillas allows following entities to bill medicare on her behalf.

Entity Name	Adelante Healthcare Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1083772545 PECOS PAC ID: 4688588643 Enrollment ID: O20031114000335

News Archive

FDA warns marketer of unapproved products claiming to treat addiction, chronic pain

The U.S. Food and Drug Administration today posted a warning letter to Nutra Pharma Corp. for illegally marketing unapproved products labeled as homeopathic with claims about their ability to treat addiction and chronic pain, including pain associated with cancer, diabetes, shingles, fibromyalgia and other serious conditions.

Children hospitalized with chronic illness more likely to underperform at school

One in every 10 kids under the age of 14 live with a chronic health condition. These conditions – which can include heart disease, diabetes and asthma – affect many areas of a child's life and, in some cases, can lead to hospitalizations that last days, weeks or even months.

Kenneth D. Steinsapir receives rare USPTO patent for Microdroplet BOTOX

Kenneth D. Steinsapir, M.D., has been issued a rare patent (US 7,846,457 B2) by The United States Patent and Trademark Office for the invention of a breakthrough method for administering cosmetic botulinum toxin. The patent for Microdroplet botulinum toxin, a nonsurgical cosmetic facial treatment that improves upon standard BOTOX treatments, was officially approved on December 7, 2010.

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Maristela Y Nabong-nillas is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Maristela Y Nabong-nillas, MD 3033 N Central Ave Ste 145, Phoenix, AZ 85012-2808 Ph: (623) 583-3001	Maristela Y Nabong-nillas, MD 1705 W Main St, Mesa, AZ 85201-6920 Ph: (623) 583-3001

News Archive

FDA warns marketer of unapproved products claiming to treat addiction, chronic pain

Children hospitalized with chronic illness more likely to underperform at school

Kenneth D. Steinsapir receives rare USPTO patent for Microdroplet BOTOX

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Pediatrics Doctors in Mesa, AZ

Jyoti S. Lebonheur, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1840 S. Stapley Drive, Suite 101, Mesa, AZ 85204 Phone: 480-464-8500
Dr. Eric Gabriel Gonzalez, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 616 E Southern Ave, #103, Mesa, AZ 85204 Phone: 602-569-3999 Fax: 602-569-3887
Pacita Tee Opulencia, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 59 S Hibbert, Mesa, AZ 85210 Phone: 480-344-6226 Fax: 602-344-6201
Dr. Daniel E Miga, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1432 S Dobson Rd Ste 512, Mesa, AZ 85202 Phone: 480-412-6336 Fax: 480-412-8013
Naresh Reddivalla, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1432 S Dobson Rd Ste 107, Mesa, AZ 85202 Phone: 480-412-4100
Dale W Guthrie, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4540 E Baseline Rd, Suite 108, Mesa, AZ 85206 Phone: 480-892-3880 Fax: 480-545-4551
Dr. Leno Mammen Thomas, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1432 S Dobson Rd Ste 506, Mesa, AZ 85202 Phone: 480-412-6430

Maristela Y Nabong-nillas, MD - Medicare Pediatrics in Mesa, AZ

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

FDA warns marketer of unapproved products claiming to treat addiction, chronic pain

Children hospitalized with chronic illness more likely to underperform at school

Kenneth D. Steinsapir receives rare USPTO patent for Microdroplet BOTOX

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

FDA warns marketer of unapproved products claiming to treat addiction, chronic pain

Children hospitalized with chronic illness more likely to underperform at school

Kenneth D. Steinsapir receives rare USPTO patent for Microdroplet BOTOX

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Pediatrics Doctors in Mesa, AZ